C Jorgensen

731 total citations
19 papers, 468 citations indexed

About

C Jorgensen is a scholar working on Rheumatology, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, C Jorgensen has authored 19 papers receiving a total of 468 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Rheumatology, 6 papers in Genetics and 5 papers in Pathology and Forensic Medicine. Recurrent topics in C Jorgensen's work include Rheumatoid Arthritis Research and Therapies (13 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). C Jorgensen is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (13 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). C Jorgensen collaborates with scholars based in France, Netherlands and Czechia. C Jorgensen's co-authors include J Sany, Patrice Taourel, C. Cyteval, E Thomas, F Blotman, M. Pierre Sarrabère, Juan‐Manuel Anaya, Bernard Combe, F. Canovas and Safa Saker and has published in prestigious journals such as Annals of the Rheumatic Diseases, American Journal of Roentgenology and Osteoarthritis and Cartilage.

In The Last Decade

C Jorgensen

18 papers receiving 448 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C Jorgensen France 9 253 207 168 65 45 19 468
R.M. Flipo France 10 408 1.6× 357 1.7× 172 1.0× 18 0.3× 85 1.9× 30 645
J J Kaye United States 10 145 0.6× 82 0.4× 404 2.4× 48 0.7× 43 1.0× 15 532
Maria Thornemo Sweden 9 126 0.5× 167 0.8× 156 0.9× 62 1.0× 17 0.4× 11 434
W. Leroy Griffing United States 11 158 0.6× 178 0.9× 233 1.4× 81 1.2× 65 1.4× 17 587
Johanne Morvan France 11 233 0.9× 66 0.3× 199 1.2× 37 0.6× 55 1.2× 15 524
Masafumi Itoh Japan 11 166 0.7× 76 0.4× 38 0.2× 72 1.1× 31 0.7× 41 321
Dewi Guellec France 13 232 0.9× 71 0.3× 216 1.3× 68 1.0× 38 0.8× 45 573
B. Haraoui Canada 7 107 0.4× 79 0.4× 429 2.6× 86 1.3× 75 1.7× 15 540
Marine Forien France 13 128 0.5× 45 0.2× 246 1.5× 46 0.7× 106 2.4× 42 476
J Saklatvala United Kingdom 8 210 0.8× 52 0.3× 474 2.8× 29 0.4× 35 0.8× 10 601

Countries citing papers authored by C Jorgensen

Since Specialization
Citations

This map shows the geographic impact of C Jorgensen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C Jorgensen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C Jorgensen more than expected).

Fields of papers citing papers by C Jorgensen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C Jorgensen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C Jorgensen. The network helps show where C Jorgensen may publish in the future.

Co-authorship network of co-authors of C Jorgensen

This figure shows the co-authorship network connecting the top 25 collaborators of C Jorgensen. A scholar is included among the top collaborators of C Jorgensen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C Jorgensen. C Jorgensen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Schordan, Eric, Hüseyin Firat, Nadir Arber, et al.. (2018). FRI0675 Rabiopred, an innovative theranostic tool to assist clinicians select an optimal anti-tnf alpha biological therapy for rheumatoid arthritis patients. Annals of the Rheumatic Diseases. 77. 857–858. 1 indexed citations
2.
Schelbergen, R., Menno ter Huurne, Johannes Roth, et al.. (2014). Treatment efficacy of adipose-derived stem cells in experimental osteoarthritis is driven by high synovial activation and reflected by S100A8/A9 serum levels. Osteoarthritis and Cartilage. 22(8). 1158–1166. 69 indexed citations
3.
Pers, Yves‐Marie, Marie Godfrin-Valnet, Joseph Lambert, et al.. (2014). AB0453 Response to TOCILIZUMAB in Rheumatoid Arthritis is not Influenced by the Body Mass Index of the Patient. Annals of the Rheumatic Diseases. 73. 958–958. 14 indexed citations
4.
5.
Pers, Yves‐Marie, Élodie Constant, Joseph Lambert, et al.. (2012). THU0126 Multicenter retrospective study: Response to tocilizumab in clinical practice is not influenced by the number of previous biotherapy or by association with a DMARD. Annals of the Rheumatic Diseases. 71. 197–197. 1 indexed citations
6.
Présumey, Jessy, C Jorgensen, Gabriel Courties, & Florence Apparailly. (2010). Myeloid cell subsets dynamic during progression of mouse collagen-induced arthritis. Journal of Translational Medicine. 8(S1). 1 indexed citations
7.
Jd, Cohen, et al.. (2009). ANCA positive polyarthritis revealing Whipple's disease.. PubMed. 26(3 Suppl 49). S154–S154. 2 indexed citations
8.
Jorgensen, C, Florence Apparailly, & J Sany. (1999). Immunological evaluation of cytokine and anticytokine immunotherapy in vivo: what have we learnt?. Annals of the Rheumatic Diseases. 58(3). 136–141. 12 indexed citations
9.
Cyteval, C., M. Pierre Sarrabère, E Thomas, et al.. (1999). Acute osteoporotic vertebral collapse: open study on percutaneous injection of acrylic surgical cement in 20 patients.. American Journal of Roentgenology. 173(6). 1685–1690. 187 indexed citations
10.
Bologna, C, C Jorgensen, & J Sany. (1998). Methotrexate as the initial second-line disease modifying agent in the treatment of rheumatoid arthritis patients.. PubMed. 15(6). 597–601. 5 indexed citations
11.
Jorgensen, C, et al.. (1997). Inflammatory joint disease after immunizations. A report of two cases.. PubMed. 64(4). 227–32. 4 indexed citations
12.
Bologna, C, C Jorgensen, & J Sany. (1997). Association of methotrexate and corticosteroids in the treatment of patients with rheumatoid arthritis.. PubMed. 14(4). 401–6.
13.
Rème, Thierry, et al.. (1995). Growth factor activity of IL-6 in the synovial fluid of patients with rheumatoid arthritis.. PubMed. 12(6). 595–602. 13 indexed citations
14.
Bologna, C, Juan‐Manuel Anaya, Françoise Bressolle, et al.. (1995). Correlation between methotrexate pharmacokinetic parameters, and clinical and biological status in rheumatoid arthritis patients.. PubMed. 13(4). 465–70. 9 indexed citations
15.
Sany, J, C Jorgensen, Juan‐Manuel Anaya, et al.. (1993). Arthritis associated with primary agammaglobulinemia: new clues to its immunopathology.. PubMed. 11(1). 65–9. 11 indexed citations
16.
Sany, J, Juan‐Manuel Anaya, F. Canovas, et al.. (1993). Influence of methotrexate on the frequency of postoperative infectious complications in patients with rheumatoid arthritis.. PubMed. 20(7). 1129–32. 87 indexed citations
17.
Anaya, Juan‐Manuel, C Jorgensen, J.P. Daurès, Bernard Combe, & J Sany. (1992). Taux de maintenance thérapeutique du méthotrexate au cours de la polyarthrite rhumatoïde. Etude prospective de 191 cas.. 59(3). 1 indexed citations
18.
Anaya, Juan‐Manuel, et al.. (1992). [Therapeutic maintenance dose with methotrexate in rheumatoid polyarthritis. Prospective study of 191 cases].. PubMed. 59(3). 181–7. 5 indexed citations
19.
Anaya, Juan‐Manuel, et al.. (1992). Non-Hodgkin's lymphoma associated with primary Sjögren's syndrome.. PubMed. 1(6). 337–42. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026